• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Swelling (2091); Vomiting (2144); Post Operative Wound Infection (2446); Abdominal Distention (2601)
Event Date 01/08/2016
Event Type  Injury  
Manufacturer Narrative
Multiple products were implanted -unknown rhbmp-2/acs, unknown bone graft matirx, (prod.Id/lot no./qty)- (2922245/xd29/1); (2152212/92ah/1); (2922250/yz25/1); (2922245/38ag/1) it is unknown which product caused the adverse event.We are filing this mdr for notification purpose.(b)(4).Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.
 
Event Description
Initial diagnosis: spinal stenosis l4-l5: left lateral recess, left foraminal, right lateral recess, right foraminal l5-s1: left lateral recess, left foraminal, right lateral recess, right foraminal mechanical instability l2-l3, l3-l4, l4-l5, l5-s1 multilevel discopathies l2-s1 it was reported that on: on (b)(6) 2015: patient presented with neurological disorder: radiculopathy.The patient also had pain with a score of 4.On (b)(6) 2016 the patient underwent anterior and posterior instrumentation at l2-s1.One cage was implanted at levels l2-l3; l3-4; l4-5 and one cage was implanted at l5-s1.On (b)(6) 2016 post-op, the patient reported an ileus.The patient was hospitalized for eight days.The event was reported as not related.The outcome of this event was resolved without sequela.Wound infection was located at the posterior lumbar, central incision l2-s1.Approximately seventeen (17) days postoperatively, the subject was reported to have a deep wound infection.The subject was admitted to the hospital (b)(6) 2016.Site reports ¿picc line in place, intra-op cx + enterobacter cloacae on levoquin, vac in place.¿ the event was reported as not related.The outcome of this event is pending.Approximately thirty days (30 days postoperatively), the subject reported a left leg dvt.The subject was hospitalized.On (b)(6) 2016: patient underwent an oblique lumbar interbody fusion and rhbmp-2, bone graft matirx was used.On (b)(6) 2016: the patient presented with fever, nausea, vomiting and abdominal distention.The patient presented with gastro-intestinal.On (b)(6) 2016: the patient presented with deep wound infection.The wound infection was located at posterior lumbar.On (b)(6) 2016, patient presented with left leg swelling and pain.Musculoskeletal examination: some tenderness to palpation on the left thigh.Patient underwent venous color doppler ultrasound, left lower extremity.Impression: non occlusive thrombus within the left common femoral vein.On (b)(6) 2016: patient underwent a treatment with diagnosis: dvt, left leg ongoing problem.
 
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that on: (b)(6) 2016, the patient underwent an interbody fusion + anterior instrumentation (l2-s1).Approximately three months postoperatively,the patient reported a diagnosis of right leg dvt by internal physician.The patient reported she was not hospitalized for this event.The investigator noted the event was not related.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK
1800 pyramid place
memphis TN 38132
Manufacturer Contact
greg anglin
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key5440513
MDR Text Key38286542
Report Number1030489-2016-00491
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/04/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/17/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/04/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age00067 YR
Patient Weight70
-
-